Article info

Download PDFPDF
Original article
Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population

Authors

  • Eva Doorakkers Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Jesper Lagergren Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden School of Cancer Sciences, King’s College London, London, UK PubMed articlesGoogle scholar articles
  • Lars Engstrand Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden Science for Life Laboratory, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Nele Brusselaers Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden Science for Life Laboratory, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Eva Doorakkers, Upper Gastrointestinal Surgery, Department of Molecular medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm 17176, Sweden; eva.doorakkers{at}ki.se
View Full Text

Citation

Doorakkers E, Lagergren J, Engstrand L, et al
Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population

Publication history

  • Received September 28, 2017
  • Revised January 10, 2018
  • Accepted January 14, 2018
  • First published January 30, 2018.
Online issue publication 
January 19, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.